Amedisys Inc's Chief Financial Officer just disposed of 2,015 shares

Scott G Ginn, Amedisys Inc's Chief Financial Officer, recently disposed of 2,015 shares of the company. The disposals took place at prices ranging from $27.35 to $119.01 per share, on November 12, 2018. Ginn still owns 15,425 shares of the company. Ginn operates out of Baton Rouge, LA. Some additional info was provided as follows:

The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.46 to $116.40, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.49 to $117.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.49 to $118.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.49 to $119.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. The information in this report is based on a plan statement dated as of September 30, 2018. On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2015 were met, resulting in vesting of the option as to 5,625 shares (the "2015 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2015 Tranche Options vested on May 1, 2016, one-third of the 2015 Tranche Options vested on May 1, 2017 and one-third of the 2015 Tranche Options vested on May 1, 2018. On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2016 were met, resulting in vesting of the option as to 5,625 shares (the "2016 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2016 Tranche Options vested on May 1, 2017, one-third of the 2016 Tranche Options vested on May 1, 2018 and one-third of the 2016 Tranche Options will vest on May 1, 2019, provided that the reporting person remains continuously employed by the Issuer on such date, subject to pro-rated vesting provisions as provided in the award agreement for the stock option.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Amedisys Inc makes a similar move, sign up!

Other recent filings from the company include the following:

Amedisys Inc director just disposed of 1,863 shares - June 17, 2019
Submission of Matters to a Vote of Security - June 13, 2019
Amedisys Inc's See Remarks just cashed-in 8,125 options - June 12, 2019
Amedisys Inc's Chief Financial Officer just disposed of 4,872 shares - June 12, 2019
Amedisys Inc director just picked up 1,297 shares - June 11, 2019

Auto Refresh

Feedback